The deleterious effects of propranolol on patients with cirrhosis

Hepatology

Volumn 53, Issue 1, 2011, Pages 371-372

  Efe, Cumali ^a   Purnak, Tugrul ^a   Ozaslan, Ersan ^a  

^a Numune Research and Education Hospital ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PROPRANOLOL;

ARTERIAL PRESSURE; ASCITES; DRUG CONTRAINDICATION; GASTROINTESTINAL HEMORRHAGE; HEART INDEX; HUMAN; HYPONATREMIA; INDEPENDENT VARIABLE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY PERFUSION; LETTER; LIVER CIRRHOSIS; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; SURVIVAL;

CARDIAC OUTPUT; HUMANS; HYPONATREMIA; LIVER CIRRHOSIS; PROPRANOLOL; RENAL INSUFFICIENCY;

EID: 78751510275     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23881     Document Type: Letter

References (3)

1. Sersté T, Melot C, Francoz C, Durand F, Rautou PE, Valla D, et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology 2010; doi:10.1002/hep.23775.
2. Krag A, Bendtsen F, Henriksen JH, Møller S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut 2010; 59: 105-110.
3. Sharma P, Kumar A, Jha S, Mishra SR, Sharma BC, Sarin SK. The hemodynamic response to propranolol in cirrhosis with arterial hypertension: a comparative analysis with normotensive cirrhotic patients. Aliment Pharmacol Ther 2010; 32: 105-112.